Morphine Completed Phase 3 Trials for Cancers, Pain Supportive Care

IndicationsStatusPurposePhase
CompletedSupportive Care3
clinicaltrials.gov IdentifierTitleDrugs
NCT00589823Efficacy and Safety Study of Nasalfent for Treatment of Breakthrough Cancer Pain in Patients Taking Regular Opioids